English
Home > Products > CAS:595-33-5

China CAS:595-33-5 Manufacturer

Our growth depends to the superior products ,great talents and repeatedly strengthened technology forces for CAS:595-33-5, Our firm quickly grew in size and reputation because of its absolute dedication to superior quality manufacturing, substantial price of solutions and fantastic customer services.
CAS:595-33-5, Our company insists on the principle of "Quality First, Sustainable Development", and takes "Honest Business, Mutual Benefits" as our developable goal. All members sincerely thank all old and new customers' support. We'll keep working hard and offering you the highest-quality goods and service.

Related Products

Hot Products

  • Desonide

    Desonide

    Desonide has USP and EP specifications. DMF available.

    CAS:638-94-8

  • Mifepristone

    Mifepristone

    Mifepristone has specifications of CP and IP. DMF and GMP approved.

    CAS:84371-65-3

  • Megestrol Acetate

    Megestrol Acetate

    Megestrol acetate has CP, EP and USP specifications. DMF under filing.

    CAS:595-33-5

  • Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride

    Valganciclovir Hydrochloride has USP specification. DMF approved.

    CAS:175865-59-5

  • 17a-Hydroxyprogesterone Acetate

    17a-Hydroxyprogesterone Acetate

    17a-Hydroxyprogesterone Acetate is an endogenous progesteroid hormone similar to progesterone.

    CAS:302-23-8

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • Related Blog
  • Reviews

  • 2022 API Exhibition Qingdao

    August 2022
    Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
    Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
    99% manufactures meets the requirements of GMP.
    Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

  • 2022 CPhI Exhibition Shanghai

    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • Visit us at Milan CPHI - Booth 3A65!

    We're looking forward to welcoming you!

  • 2025 Corporate Exhibition Calendar Officially Released !

    Our 2025 Exhibition Calendar has been announced! Come meet our team and explore new business opportunities.We look forward to seeing you there!

  • What is Progesterone?

    Progesterone helps regulate the menstrual cycle, supports early pregnancy by maintaining the uterine lining, and contributes to breast health. For individuals with hormonal imbalances, infertility, or specific medical conditions, supplemental progesterone can be essential.

  • How Can Intermediates Category Solutions Streamline Your Production Process

    As someone who has spent over two decades navigating the complexities of industrial production, I've seen firsthand how bottlenecks in the middle stages can derail entire operations. That’s why I was particularly impressed when I began working with solutions from the Intermediates Category. For any production manager, finding tools that seamlessly integrate and accelerate the core of your workflow is the ultimate goal. This is where the strategic approach from Humanwell truly shines, offering a refined path to efficiency that many of us have been searching for.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept